Should I Buy CRH? CRH 2026 Analysis

Should You Buy CRH PLC (CRH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

127.130

1 Day change

4.40%

52 Week Range

131.550

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now: Risk/reward is acceptable at ~$122 with supportive fundamentals (Q3 growth), bullish options positioning, and mostly positive Street targets well above the current price.
Near-term path: Price is sitting just above first support (~~121.4); a push back toward the pivot (~~124.2) is the most immediate upside objective.
Intellectia Proprietary Trading Signals
- AI Stock Picker: No signal on given stock today.
- SwingMax: No signal on given stock recently.

Technical Analysis

Trend/momentum: Mixed-to-neutral. MACD histogram is negative (-0.147) but negatively contracting (bearish momentum fading).
RSI: RSI(6) ~51.5 = neutral (no overbought/oversold edge).
Moving averages: Converging MAs suggest consolidation rather than a strong trend.
Key levels:
- Support: S1 121.40, then S2 119.69 (a break below S1 would weaken the setup).
- Resistance: Pivot 124.15, then R1 126.91 (needs a reclaim of pivot to confirm near-term upside).
Pattern-based forward odds (given dataset): Moderate bullish skew near term (next week +3.76% scenario noted), but not a high-conviction technical breakout setup today.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Bullish tilt—put/call ratios are low (both OI and especially volume), implying calls are favored.
Positioning/flow: Today’s volume is light vs recent averages (todays volume 1036 vs 5d/10d avgs ~1515/1682), suggesting no “panic” hedging or euphoric chase.
Volatility: 30D IV ~32.22 vs historical vol ~18.53 (options pricing in elevated moves). IV percentile ~52 (mid-range), so not extremely crowded either way.
Takeaway: Options market is leaning constructive (call-heavy) without extreme IV—supports a buy-now stance.

Technical Summary

Sell

Buy

Positive Catalysts

on 2026-02-18 after hours—a potential upside trigger if guidance/infra demand trends are strong.

Neutral/Negative Catalysts

and still in a consolidation regime; no breakout confirmation yet.

Financial Performance

Latest quarter provided: 2025/Q3
- Revenue: $11.07B, +5.27% YoY (steady top-line growth).
- Net Income: $1.503B, +9.23% YoY (profit growing faster than revenue).
- EPS: 2.23, +10.95% YoY (solid earnings momentum).
- Gross Margin: 38.93%, +0.85 YoY (modest margin expansion).
Read-through: Consistent growth + improving margins supports buying even without a perfect technical setup.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Mostly constructive; several firms raised/initiated with bullish targets, though there was a notable Wells Fargo PT cut and Equal Weight stance.
Notable updates:
- Citi: Buy, PT $155 (prefers heavy construction/infra exposure).
- UBS: Buy, PT $147.
- Longbow: Initiated Buy, PT $160.
- JPMorgan: Overweight, PT $135.
- Wells Fargo: Equal Weight, PT $133 (more cautious/selective).
Wall Street pros: Infrastructure/heavy materials preference, multiple PTs far above current price.
Wall Street cons: Some caution on cycle timing/selection within building materials; at least one neutral-rated view remains.

14 Analyst Rating

Wall Street analysts forecast CRH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRH is 142.05 USD with a low forecast of 131 USD and a high forecast of 164 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

13 Buy

1 Hold

0 Sell

Strong Buy

Current: 121.770

Low

131

Averages

142.05

High

164

Current: 121.770

Low

131

Averages

142.05

High

164

Wells Fargo

Equal Weight

downgrade

$138 -> $133

AI Analysis

2026-01-29

Reason

Wells Fargo

Price Target

$138 -> $133

AI Analysis

2026-01-29

downgrade

Equal Weight

Reason

Wells Fargo lowered the firm's price target on CRH to $133 from $138 and keeps an Equal Weight rating on the shares. The firm remains selective in its building mats recommendations, preferring early-cycle exposure as Wells anticipates some housing/remodeling recovery.

UBS

Buy

maintain

$138 -> $147

2026-01-08

Reason

UBS

Price Target

$138 -> $147

2026-01-08

maintain

Buy

Reason

UBS raised the firm's price target on CRH to $147 from $138 and keeps a Buy rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CRH

Unlock Now

CRH Should I Buy

CRH Should I Buy

Should You Buy CRH PLC (CRH) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch